Related references
Note: Only part of the references are listed.Development of a unified clinical trial database for Alzheimer's disease
Jon Neville et al.
ALZHEIMERS & DEMENTIA (2015)
An Improved Model for Disease Progression in Patients From the Alzheimer's Disease Neuroimaging Initiative
Mahesh N. Samtani et al.
JOURNAL OF CLINICAL PHARMACOLOGY (2012)
Combining patient-level and summary-level data for Alzheimer's disease modeling and simulation: a beta regression meta-analysis
James A. Rogers et al.
JOURNAL OF PHARMACOKINETICS AND PHARMACODYNAMICS (2012)
A double-blind, delayed-start trial of rasagiline in Parkinson's disease (the ADAGIO study): prespecified and post-hoc analyses of the need for additional therapies, changes in UPDRS scores, and non-motor outcomes
Olivier Rascol et al.
LANCET NEUROLOGY (2011)
The Coalition Against Major Diseases: Developing Tools for an Integrated Drug Development Process for Alzheimer's and Parkinson's Diseases
K. Romero et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2009)
Share Paper
